Overcoming vulnerability in heart failure: Transitional tactical toughness
Francesco Castagna,
Panagiotis Simitsis,
Mandeep R. Mehra
Abstract:This article refers to 'Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period: The multinational randomized LeoDOR trial' by G. Pölzl et al., published in this issue on pages 2007-2017.
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.